Medicine Online
Any medical inquiries? Search MOL for answers:
NEWS
Home > News > 2008 > July > 29 > First Generic Versions of Depakote Approved
Medical References
Diseases & Conditions
Women's Health
Mental Health
Men's Health
Healthy Choice News
Site Map Links
Medical Tips
Attention, chocolate lovers: You may not be able to help yourselves. Swiss and British scientists have linked the widespread love of chocolate to a chemical "signature" that may be programmed into our metabolic systems.
Read more health news

First Generic Versions of Depakote Approved

TUESDAY, July 29 (HealthDay News) -- The first generic versions of Depakote (divalproex sodium) have been approved by the U.S. Food and Drug Administration to treat epileptic seizures, migraine headaches and bipolar disorder, the agency said Tuesday.

Eight firms were granted license to produce generic versions of the brand-name drug made by Abbott Laboratories. The generics will have the same label warnings as the brand-name medication, including cautions about increased risk of severe liver damage, inflamed pancreas, and neural tube birth defects.

"Generic drugs undergo a rigorous scientific review to ensure that they will provide the patient with the same amount of high quality, safe and effective drug as the name brand product," Gary Buehler, director of the FDA''s Office of Generic Drugs, said in an agency news release.

More information

To learn more about this drug, also called valproic acid, visit the U.S. government''s MedlinePlus site.



-- Scott Roberts

Last Updated: July 29, 2008

Copyright © 2008 ScoutNews, LLC. All rights reserved.

HomeSitemap Contact UsAdvertisingPress RoomGive Us Your FeedbackRead Our Terms & Conditions and Our DisclaimerPrivacy Statement